Singapore, Nov. 3 -- China's Qyuns Therapeutics has entered into a global exclusive collaboration and license agreement with F. Hoffmann-La Roche Ltd, pursuant to which the Company grants Roche the global exclusive right to develop, manufacture, and commercialize QX031N.

Published by HT Digital Content Services with permission from BioSpectrum Asia....